Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Werner Poewe

Showing results (451-460 of 602) with videos related to

Pageof 61
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2022
Family History for Neurodegeneration in Multiple System Atrophy: Does it Indicate Susceptibility?Fabian Leys, Sabine Eschlböck, Nicole Campese, et al.
The Lancet. Neurology|April 13, 2011
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomesOlivier Rascol, Cheryl J Fitzer-Attas, Robert Hauser, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 27, 2016
The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approachJohannes Levin, Sylvia Maaß, Madeleine Schuberth, et al.
Movement Disorders Clinical Practice|May 8, 2024
Long-Term Medication Profiles in Parkinson's Disease under Subthalamic Deep Brain Stimulation: A Controlled StudyChristoph Theyer, Vincent Beliveau, Florian Krismer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 12, 2014
Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorderAlex Iranzo, Heike Stockner, Mónica Serradell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 21, 2007
Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphyMartin Köllensperger, Klaus Seppi, Claudia Liener, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 16, 2008
Anxiety rating scales in Parkinson's disease: critique and recommendationsAlbert F G Leentjens, Kathy Dujardin, Laura Marsh, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 19, 2008
Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendationsAlbert F G Leentjens, Kathy Dujardin, Laura Marsh, et al.
The Lancet. Neurology|April 16, 2013
Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunitiesDaniela Berg, Anthony E Lang, Ronald B Postuma, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 22, 2019
Early distinction of Parkinson-variant multiple system atrophy from Parkinson's diseaseAlessandra Fanciulli, Georg Goebel, Giulia Lazzeri, et al.
Pageof 61

Showing results (451-460 of 602) with videos related to

Sort By:
Pageof 61
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2022
Family History for Neurodegeneration in Multiple System Atrophy: Does it Indicate Susceptibility?Fabian Leys, Sabine Eschlböck, Nicole Campese, et al.
The Lancet. Neurology|April 13, 2011
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomesOlivier Rascol, Cheryl J Fitzer-Attas, Robert Hauser, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 27, 2016
The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approachJohannes Levin, Sylvia Maaß, Madeleine Schuberth, et al.
Movement Disorders Clinical Practice|May 8, 2024
Long-Term Medication Profiles in Parkinson's Disease under Subthalamic Deep Brain Stimulation: A Controlled StudyChristoph Theyer, Vincent Beliveau, Florian Krismer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 12, 2014
Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorderAlex Iranzo, Heike Stockner, Mónica Serradell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 21, 2007
Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphyMartin Köllensperger, Klaus Seppi, Claudia Liener, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 16, 2008
Anxiety rating scales in Parkinson's disease: critique and recommendationsAlbert F G Leentjens, Kathy Dujardin, Laura Marsh, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 19, 2008
Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendationsAlbert F G Leentjens, Kathy Dujardin, Laura Marsh, et al.
The Lancet. Neurology|April 16, 2013
Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunitiesDaniela Berg, Anthony E Lang, Ronald B Postuma, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 22, 2019
Early distinction of Parkinson-variant multiple system atrophy from Parkinson's diseaseAlessandra Fanciulli, Georg Goebel, Giulia Lazzeri, et al.
Pageof 61